A Randomized, Prospective and Crossover Study, Comparing the Eradication Rate After 10 Days of Concomitant Therapy to Bismuth Quadruple Therapy Among a Sample of the Lebanese Population
Bismuth quadruple therapy and concomitant therapy are both equally effective first-line treatment regimens for the eradication of <i>H pylori</i>. They are also effective if used as second-line treatment regimens for this purpose. Lebanese Clinical Trials Registry identifier: LBCTR2024095653.
Authors
- Jad Chidiac
- Yara Yazbeck
- Reine-Marie Kahwaji
- Souheil R. Hallit (ORCID: https://orcid.org/0000-0001-6918-5689)
- Charbel Yazbeck
- Bassem Akiki
Institutions
- Effat University (SA)
- Applied Science Private University (JO)
- Holy Spirit University of Kaslik (LB)
- Université Paris-Saclay (FR)
- Institut des Neurosciences Paris-Saclay (FR)
- Centre Hospitalier Universitaire Notre Dame des Secours (LB)
Publication Details
- Journal
- Current Therapeutic Research
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.curtheres.2025.100791
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00